Pathways to Parkinson's disease: a spotlight on 14-3-3 proteins.

Pathways to Parkinson's disease: a spotlight on 14-3-3 proteins.
复制标题

DOI:
10.1038/s41531-021-00230-6
复制
发表时间:
2021-09-21
期刊:
NPJ Parkinson's disease
影响因子:
--
通讯作者:
Civiero L
Civiero L
中科院分区:
其他
文献类型:
--
作者:
Giusto E;Yacoubian TA;Greggio E;Civiero L

文献摘要

参考文献

被引文献

相似文献

14-3-3s代表高度保守的30 kDa酸性蛋白家族。14-3-3s识别并结合客户伙伴上的特定磷酸序列,并作为分子枢纽来调节其活性、定位、折叠、降解和蛋白质-蛋白质相互作用。14-3-3s还与几种疾病的发病机制有关,其中包括帕金森病(PD)。14-3- 3在PD患者的路易体(LB)中被发现,并且它们的神经保护作用已经在几种PD动物模型中得到证实。值得注意的是,14-3-3s与已知参与PD发病机制的一些主要蛋白质相互作用。在这里,我们首先提供了一个详细的概述14-3-3s的分子组成和结构特征,重点放在其独特的目标结合机制。然后,我们简要描述了14-3-3s在中枢神经系统中的意义,并重点介绍了它们与LRRK 2,α-突触核蛋白和Parkin的相互作用,这三个是PD发病和进展的主要参与者。我们最后讨论了不同类型的小分子如何干扰14-3-3s相互作用组,从而代表了未来药物发现的有效策略。
14-3-3s represent a family of highly conserved 30 kDa acidic proteins. 14-3-3s recognize and bind specific phospho-sequences on client partners and operate as molecular hubs to regulate their activity, localization, folding, degradation, and protein–protein interactions. 14-3-3s are also associated with the pathogenesis of several diseases, among which Parkinson’s disease (PD). 14-3-3s are found within Lewy bodies (LBs) in PD patients, and their neuroprotective effects have been demonstrated in several animal models of PD. Notably, 14-3-3s interact with some of the major proteins known to be involved in the pathogenesis of PD. Here we first provide a detailed overview of the molecular composition and structural features of 14-3-3s, laying significant emphasis on their peculiar target-binding mechanisms. We then briefly describe the implication of 14-3-3s in the central nervous system and focus on their interaction with LRRK2, α-Synuclein, and Parkin, three of the major players in PD onset and progression. We finally discuss how different types of small molecules may interfere with 14-3-3s interactome, thus representing a valid strategy in the future of drug discovery.
DOI: 10.1126/science.1175371
发表时间: 2009-08-14
期刊: SCIENCE
影响因子: 56.9
作者:
Choudhary, Chunaram;Kumar, Chanchal;Mann, Matthias
通讯作者: Mann, Matthias
DOI: 10.1002/mds.25421
发表时间: 2013-06-01
期刊: MOVEMENT DISORDERS
影响因子: 8.6
作者:
Appel-Cresswell, Silke;Vilarino-Guell, Carles;Farrer, Matthew J.
通讯作者: Farrer, Matthew J.
DOI: 10.3389/fnmol.2017.00417
发表时间: 2017
影响因子: 4.8
作者:
Civiero L;Cogo S;Kiekens A;Morganti C;Tessari I;Lobbestael E;Baekelandt V;Taymans JM;Chartier-Harlin MC;Franchin C;Arrigoni G;Lewis PA;Piccoli G;Bubacco L;Cookson MR;Pinton P;Greggio E
通讯作者: Greggio E
DOI: 10.1016/s0140-6736(04)17103-1
发表时间: 2004-09-25
期刊: LANCET
影响因子: 168.9
作者:
Chartier-Harlin, MC;Kachergus, J;Destée, A
通讯作者: Destée, A
DOI: 10.1093/hmg/dds522
发表时间: 2013-03-15
影响因子: 3.5
作者:
Biosa, Alice;Trancikova, Alzbeta;Moore, Darren J.
通讯作者: Moore, Darren J.